期刊文献+

腹腔镜微创外科技术对结直肠癌肝转移患者的治疗效果观察 被引量:6

Effect of laparoscopic minimally invasive surgery on colorectal cancer patients with liver metastasis
原文传递
导出
摘要 目的:探讨腹腔镜结直肠癌联合肝转移灶切除术在治疗结直肠癌肝转移(CRLM)患者中的安全性、有效性。方法:选取2018年4月至2019年6月山西省肿瘤医院结直肠肛门外科收治的42例CRLM患者,男25例,女17例,年龄(57.38±2.72)岁,年龄范围为41~78岁,根据手术方式不同将其分为腹腔镜组(n=18)与传统开腹组(n=24),腹腔镜组患者行腹腔镜结直肠癌联合肝转移灶切除术,传统开腹组行传统开腹结直肠癌联合肝转移灶切除术。比较两组患者括手术时间、术中出血量、术后肛门排气或排便时间、术后住院时间、住院费用、术后并发症(术后吻合口瘘、膈下感染、肺部感染、切口感染)发生率等。结果:腹腔镜组患者手术时间[(193.24±15.68)min]长于传统开腹组[(170.63±16.39)min]、术中出血量[(52.82±11.04)ml]少于传统开腹组[(67.16±17.40)ml]、术后住院时间[(5.14±1.03)d]短于传统开腹组[(8.42±1.61)d]、手术费用[(6.58±1.04)万元]高于传统开腹组[(5.17±1.42)万元],差异均有统计学意义(P<0.05);腹腔镜组患者术后肛门排气或排便时间[(2.37±0.82)d]与传统开腹组[(2.64±0.79)d]比较,差异无统计学意义(P>0.05)。腹腔镜组患者术后并发症发生率[16.7%(3/18)]与传统开腹组[20.9%(5/24)]比较,差异无统计学意义(P>0.05)。结论:腹腔镜结直肠癌联合肝转移灶切除术不仅治疗效果显著,而且可有效降低并发症的发生率,具有较高的安全性、有效性。 Objective To investigate the safety and efficacy of laparoscopic resection of colorectal cancer combined with liver metastasis in patients with colorectal cancer liver metastasis(CRLM).Methods A retrospective study was performed on 42 cases of patients with CRLM who were admitted from April 2018 to June 2019.There were 25 males and 17 females,aged(57.38±2.72)years old,ranging from 41 to 78 years old.According to different surgical methods,they were divided into laparoscopic group(n=18)and traditional open group(n=24).Patients of the laparoscopic group underwent laparoscopic colorectal cancer combined with liver metastasis resection,while patients in the traditional open group underwent traditional open colorectal cancer combined with liver metastasis resection.The incidence of postoperative complications(postoperative anastomotic leakage,subphrenic infection,pulmonary infection,incision infection)was compared between the two groups.Results The operating time[(193.24±15.68)minutes]in the laparotomy group was longer than[(170.63±16.39)minutes]in the traditional open group,the intraoperative blood loss in the laparotomy group[(52.82±11.04)ml]was less than[(67.16±17.40)ml]in the traditional open group,the postoperative hospitalization time[(5.14±1.03)days]was shorter than[(8.42±1.61)days]in the traditional open group,the surgery cost[(6.58±1.04)ten thousand Yuan]was higher than[(5.17±1.42)ten thousand Yuan]in the traditional open group,and the differences were statistically significant(P<0.05),postoperative anal exhaust or defecation time of patients in the laparoscopic group[(2.37±0.82)days]was not significantly different from that in the traditional laparotomy group[(2.64±0.79)days],(P>0.05).The incidence of postoperative complications in the laparoscopic group[16.7%(3/18)]compared with the traditional laparotomy group[20.9%(5/24)],the difference was not statistically significant(P>0.05).Conclusion Laparoscopic resection of colorectal cancer combined with liver metastasis has not only significant therapeutic effect,but also can effectively reduce the incidence of complications,with high safety and effectiveness.
作者 王文达 王立春 刘世洲 Wang Wenda;Wang Lichun;Liu Shizhou(Department of Colorectal Anorectal Surgery,Shanxi Cancer Hospital,Taiyuan 030000,China;Department of Emergency,Shanxi Bethune Hospital,Taiyuan 030000,China)
出处 《中国临床实用医学》 2020年第4期23-27,共5页 China Clinical Practical Medicine
关键词 结直肠癌 肝转移 腹腔镜 吻合口瘘 膈下感染 Colorectal cancer Liver metastasis Laparoscopic Anastomotic fistula Subphrenic infection
  • 相关文献

参考文献10

二级参考文献133

  • 1许岸高,姜泊,钟旭辉,余志金,刘集鸿.广东地区近20年大肠癌临床特征的变化趋势[J].中华医学杂志,2006,86(4):272-275. 被引量:86
  • 2蔡善荣,郑树,周伦,张苏展.杭州城市社区自然人群大肠癌筛查实践[J].实用肿瘤杂志,2006,21(2):177-178. 被引量:51
  • 3郑树.大肠癌高发现场病因、筛查方法及早诊早治研究[J].中国肿瘤,1996,5(5):18-19. 被引量:17
  • 4郑树,蔡善荣,张苏展.重视结直肠癌高危人群的筛查[J].中华消化杂志,2006,26(6):361-363. 被引量:41
  • 5陈峻青,夏志平.胃肠癌手术学[M].2版.北京:人民卫生出版社,2008:242-264.
  • 6Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [J]. CA Cancer J Clin, 2013, 63(1): 11-30.
  • 7Yoo PS, Lopez-Soler RI, Longo WE, et al. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemo- therapy and bevacizumab [J].Clin Colorectal Cancer, 2006, 6(3): 202-207.
  • 8Van Cutsem E, Nordlinger B, Adam R, et al. Towards a pan-Eu- ropean consensus on the treatment of patients with colorectal liv- er metastases[J]. EurJ Cancer, 2006, 42(14): 2212-2221.
  • 9Alberts SR, Horvath WL, Sternfeld WC, et al. Oxaliplatin, fluo- rouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treat- ment Group phase Ⅱ study [J]. J Clin Oncol, 2005, 23(36): 9243-9249.
  • 10Adam R, Wicherts DA, de Haas RJ, et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? [J]. J Clin Oncol, 2009, 27(11): 1829-1835.

共引文献182

同被引文献49

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部